文献速递消化系统肿瘤支持与姑息治疗

糖尿病、体重变化与胰腺癌风险

Diabetes, Weight Change, and Pancreatic Cancer Risk.
PubMed 文献 · JAMA Oncol · 2020-10-08

该队列研究基于护士健康研究和卫生专业人员随访研究,纳入112 818名女性和46 207名男性,随访30年,评估糖尿病病程和近期体重变化与胰腺癌风险的关系。结果发现,新发糖尿病伴体重下降者胰腺癌风险显著增加,尤其体重下降>8磅者风险更高。

要点

  • 新发糖尿病伴体重下降1-8磅者胰腺癌风险HR为3.61,>8磅者HR为6.75。
  • 新发糖尿病者胰腺癌风险高于长期糖尿病者(HR 2.97 vs 2.16)。
  • 体重下降前BMI<25或非有意减重者风险进一步升高。

核心结论

  • 新发糖尿病伴随体重下降与胰腺癌风险显著增加相关,尤其在高龄、体重正常及非有意减重人群中。

研究设计与样本

  • 一项队列研究,数据来自护士健康研究(女性)和卫生专业人员随访研究(男性),随访30年,纳入112 818名女性和46 207名男性,共1116例胰腺癌病例。

主要发现

  • 与无糖尿病者相比,新发糖尿病者年龄调整HR为2.97(95%CI 2.31-3.82),长期糖尿病者HR为2.16(95%CI 1.78-2.60)。
  • 与无体重下降者相比,体重下降1-4磅者HR为1.25(95%CI 1.03-1.52),5-8磅者HR为1.33(95%CI 1.06-1.66),>8磅者HR为1.92(95%CI 1.58-2.32)。
  • 新发糖尿病伴体重下降1-8磅者胰腺癌发病率为91/10万人年(95%CI 55-151),HR为3.61(95%CI 2.14-6.10);>8磅者发病率为164/10万人年(95%CI 114-238),HR为6.75(95%CI 4.55-10.00);无两者暴露者发病率为16/10万人年(95%CI 14-17)。
  • 体重下降前BMI<25者发病率达400/10万人年,非有意减重者达334/10万人年。

临床怎么用

  • 对新发糖尿病伴体重下降的患者,尤其高龄、体重正常或非有意减重者,应警惕胰腺癌风险,考虑进一步筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Pancreatic cancer is the third-leading cause of cancer death in the United States; however, few high-risk groups have been identified to facilitate early diagnosis strategies. OBJECTIVE: To evaluate the association of diabetes duration and recent weight change with subsequent risk of pancreatic cancer in the general population. DESIGN, SETTING, AND PARTICIPANTS: This cohort study obtained data from female participants in the Nurses' Health Study and male participants in the Health Professionals Follow-Up Study, with repeated exposure assessments over 30 years. Incident cases of pancreatic cancer were identified from self-report or during follow-up of participant deaths. Deaths were ascertained through reports from the next of kin, the US Postal Service, or the National Death Index. Data collection was conducted from October 1, 2018, to December 31, 2018. Data analysis was performed from January 1, 2019, to June 30, 2019. EXPOSURES: Duration of physician-diagnosed diabetes and recent weight change. MAIN OUTCOME AND MEASURES: Hazard ratios (HRs) for subsequent development of pancreatic cancer. RESULTS: Of the 112 818 women (with a mean [SD] age of 59.4 [11.7] years) and 46 207 men (with a mean [SD] age of 64.7 [10.8] years) included in the analysis, 1116 incident cases of pancreatic cancers were identified. Compared with participants with no diabetes, those with recent-onset diabetes had an age-adjusted HR for pancreatic cancer of 2.97 (95% CI, 2.31-3.82) and those with long-standing diabetes had an age-adjusted HR of 2.16 (95% CI, 1.78-2.60). Compared with those with no weight loss, participants who reported a 1- to 4-lb weight loss had an age-adjusted HR for pancreatic cancer of 1.25 (95% CI, 1.03-1.52), those with a 5- to 8-lb weight loss had an age-adjusted HR of 1.33 (95% CI, 1.06-1.66), and those with more than an 8-lb weight loss had an age-adjusted HR of 1.92 (95% CI, 1.58-2.32). Participants with recent-onset diabetes accompanied by weight loss of 1 to 8 lb (91 incident cases per 100 000 person-years [95% CI, 55-151]; HR, 3.61 [95% CI, 2.14-6.10]) or more than 8 lb (164 incident cases per 100 000 person-years [95% CI, 114-238]; HR, 6.75 [95% CI, 4.55-10.00]) had a substantially increased risk for pancreatic cancer compared with those with neither exposure (16 incident cases per 100 000 person-years; 95% CI, 14-17). Incidence rates were even higher among participants with recent-onset diabetes and weight loss with a body mass index of less than 25 before weight loss (400 incident cases per 100 000 person-years) or whose weight loss was not intentional judging from increased physical activity or healthier dietary choices (334 incident cases per 100 000 person-years). CONCLUSIONS AND RELEVANCE: This study demonstrates that recent-onset diabetes accompanied by weight loss is associated with a substantially increased risk for developing pancreatic cancer. Older age, previous healthy weight, and no intentional weight loss further elevate this risk.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Yuan C, Babic A, Khalaf N, et al. Diabetes, Weight Change, and Pancreatic Cancer Risk. JAMA Oncol. 2020. PMID: 32789511. doi:10.1001/jamaoncol.2020.2948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。